Best Growth Stocks to Buy for August 7th

Zacks highlighted three Zacks Rank #1 buy-rated growth stocks: Chewy (CHWY) with current-year EPS estimate up 1.1% over 60 days and a sub-industry PEG of 0.80 (industry 2.07); Daktronics (DAKT) with EPS estimate up 34.5% and PEG of 0.40 (industry 0.46); and Gorman-Rupp (GRC) with EPS estimate up 11.5% and PEG of 1.57 (industry 1.65). The article frames these as potential “home run” candidates aimed at +100% or more in 2024, with most picks described as underfollowed by Wall Street.

Analysis

This reads more like a revision-momentum screen than a differentiated fundamental call. The only name with enough estimate acceleration to matter near term is DAKT, where a thin float and limited sell-side coverage can turn small changes in order visibility into outsized multiple expansion. CHWY is a steadier business, but the upside is mostly multiple support unless it proves durable margin expansion; otherwise, online pet retail remains vulnerable to promo pressure and freight/last-mile costs. GRC looks like the least flashy but most durable compounder, with the market likely to reward it only when industrial/infrastructure spend stays firm.

Second-order, the article is implicitly favoring capex and replacement demand over discretionary consumption. If DAKT’s momentum is real, the benefit should extend to venue integrators, LED component suppliers, and local contractors tied to refurb cycles; if not, this becomes a classic small-cap estimate revision fade after the next print. GRC’s upside depends on municipal and industrial maintenance budgets, which are resilient but not immune to delay if rates or recession risk rise. CHWY is the most exposed to household balance-sheet pressure and could see margin leverage reverse quickly if customer acquisition costs or discounting re-accelerate.

Contrarian view: the market may already be paying for the “growth” label in CHWY, while DAKT’s revision story may be too early to trust without backlog confirmation. These kinds of stocks often outperform into earnings and then stall if guidance merely meets, not beats, the implied bar. The cleanest signal is DAKT over the next 1-2 quarters; absent proof of sustained order conversion, treat the current strength as tradeable rather than structural.

Key Decisions for Investors

• Tactically long DAKT into the next earnings window; use it as a 1-2 quarter momentum trade, but exit if bookings/backlog commentary fails to confirm the revision trend.
• Avoid initiating fresh CHWY longs here unless the next report shows gross margin expansion and lower promo intensity; otherwise the low PEG is likely a value trap rather than a catalyst.
• Accumulate GRC only on pullbacks for a 6-12 month holding period; this is a lower-beta industrial compounder, better suited to a slow re-rating than a sharp pop.